Video: Canadian International Council interviews Rafi Hofstein about...
Dr. Raphael Hofstein, president and CEO of MaRS Innovation, spoke to the Canadian International Council about the importance of protecting intellectual property as an important component in...
View ArticleLos Angeles Times covers Dr. Gregory Czarnota’s cancer therapy technology
The Los Angeles Times featured Dr. Gregory Czarnota’s research in their Science Now section on July 10, 2012, which reports on discoveries from the world of science and medicine (update: the article is...
View ArticleClik here to view.
We’ve refreshed our website: Beta version now live
We’ve refreshed our layout and added new features. Welcome to the beta version of the MaRS Innovation website. We have refreshed the site’s design to make better use of its existing functionality while...
View ArticleClik here to view.
MI Inventors Poon and Rahnama Pitch EMTech 2012 (Videos Online)
Being named to the MIT Technology Review‘s 35 Inventors Under 35 list is a prestigious honour, but one of its best perks is the subsequent invitation to attend the Emerging Technologies conference...
View ArticleClik here to view.
Spin-off Snapshot: Flybits, OtoSim, ApneaDX, ScarX Therapeutics
Happy New Year. Here’s a snapshot of some spin-off stories you may have missed over the holiday break. Flybits and Flybits Lite, the startup company’s context-aware mobile technology that anyone can...
View ArticleClik here to view.
Biotechnology Focus’ December issue covers MaRS Innovation projects and...
Stem Cell Therapeutics Corp. MaRS Innovation’s (MI) projects and partnerships earned three separate article mentions in the December 2012 issue of Biotechnology Focus, including: MI and UHN’s...
View ArticleClik here to view.
Globe and Mail and Global News Toronto cover early-stage Bio Printer technology
U of T Ph.D. student Lian Leng demonstrates how the Bio Printer prototype creates new skin cells. Screen shot courtesy of Global News Toronto. An early-stage technology that may revolutionize the way...
View ArticleClik here to view.
MaRS Innovation awarded $15 million to further commercialize world-leading...
Networks of Centres of Excellence recognizes strength of partnership between MI and its 16 member institutions TORONTO, February 5, 2013 — How do you make sure the brilliant ideas emerging from...
View ArticleClik here to view.
What does MaRS Innovation’s funding extension mean for Toronto’s academic...
Every six weeks, MaRS Innovation’s marketing and communications manager writes a guest post for the MaRS Discovery District blog profiling MI’s activities or one of our start-up companies. You can read...
View ArticleClik here to view.
Stem Cell Therapeutics licenses UHN’s Clinical Cancer Stem Cell Program
Stem Cell Therapeutics Corp. Stem Cell Therapeutics Corp. (TSX-V: SSS), a biopharmaceutical company developing cancer stem cell-related technologies, has signed a definitive license agreement with...
View ArticleClik here to view.
WaveCheck to Transform Chemotherapy Monitoring for Women with Breast Cancer
Indiegogo campaign to raise funds for North American clinical study during Breast Cancer Awareness Month; 12 artists donate 13 original works worth over $15,000 to support campaign Dr. Gregory Czarnota...
View ArticleClik here to view.
WaveCheck raises over $41,000 for breast cancer treatment monitoring in three...
Over 340 people worldwide have joined WaveCheck‘s Indiegogo crowdfunding campaign to fund a breakthrough clinical technique for breast cancer that promises to revolutionize the way chemotherapy is...
View ArticleClik here to view.
Simple test could replace surgery to diagnose male infertility
Dr. Keith Jarvi (left), Head of Urology and Director of the Murray Koffler Urologic Wellness Centre and Dr. Andrei Darbovich, lead author of the paper. Mount Sinai’s Lunenfeld-Tanenbaum Research...
View ArticleClik here to view.
MaRS Innovation and Pfizer Fund Bio-Manufacturing Technology
Technology developed by Dr. Stuart Berger at UHN is first project funded through partnership Dr. Stuart Berger, senior scientist at University Health Network, has developed a potential innovation for...
View ArticleClik here to view.
Portfolio snapshot: UTEST in the Wall Street Journal, OtoSim & Sylleta win...
Here’s a snapshot of some recent portfolio activity: UTEST, the early-stage technology accelerator MI runs in partnership with the University of Toronto, was cited in the Wall Street Journal as part of...
View ArticleClik here to view.
MaRS Innovation collaborating with Johnson & Johnson Innovation and Janssen...
TORONTO, Jan. 12, 2015 — MaRS Innovation, the commercialization agent for Ontario’s 15 leading academic institutions, today announced that it has formed a research collaboration with Johnson &...
View Article
